“…A total of 15 studies analyzed GM-CSF, and 12 found increased levels in dengue patients, half of whom had severe dengue, in contrast with nonsevere dengue and/or healthy controls [ 12 , 37 , 38 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 ], including 1 study in children only [ 48 ]. The increase in GM-CSF levels is evident mainly in the critical phase [ 12 , 37 , 38 , 46 , 52 ], and elevated GM-CSF levels are associated with clinical manifestations of severe dengue, such as cavitary effusion [ 46 ], hypotension [ 45 ], and encephalitis [ 48 ].…”